Results 61 to 70 of about 20,708 (216)

The anti‐fibrotic effects of novel heart failure pharmacotherapies in advanced heart failure patients

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 7, Page 1502-1516, April 2026.
Background and Purpose Novel heart failure (HF) pharmacotherapies, including angiotensin receptor‐neprilysin inhibitor (ARNI) and sodium‐glucose cotransporter 2 inhibitors (SGLT2is), may confer cardiovascular benefits by attenuating myocardial fibrosis. However, direct evidence from human failing myocardial samples is limited.
Dávid Nagy   +10 more
wiley   +1 more source

Rejection Surveillance: Integrating Cell-Free DNA and Gene Expression Panels to Decrease Invasiveness in Routine Monitoring of Heart Transplant Recipients

open access: yesMethodist DeBakey Cardiovascular Journal
Post-transplant rejection surveillance remains a cornerstone of heart transplant care. Although endomyocardial biopsy has long been the gold standard for monitoring rejection, its invasiveness and limitations have driven innovations in noninvasive ...
Hatem Alansari, Janardhana R. Gorthi
doaj   +1 more source

Is arrhythmogenic right ventricular cardiomyopathy a paediatric problem too? [PDF]

open access: yes, 2001
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heart muscle disease that is often familial, characterized by arrhythmias of right ventricular origin, due to transmural fatty or fibrofatty replacement of atrophic myocardium. ARVC is usually
Basso, Cristina   +4 more
core  

Abnormal Myocardial Blood Flow Reserve Observed in Cardiac Amyloidosis [PDF]

open access: yes, 2016
We performed real-time myocardial contrast echocardiography on a patient with cardiac amyloidosis and previous normal coronary angiography presenting with atypical chest pain to assess myocardial blood flow reserve (MBFR).
Greaves, K, Nam, MC, Nel, K, Senior, R
core   +1 more source

Incremental Prognostic Value of Heart‐Type Fatty Acid Binding Protein in Patients With Light Chain Cardiac Amyloidosis: A Prospective Cohort Study

open access: yesClinical and Translational Science, Volume 19, Issue 4, April 2026.
Baseline heart‐type fatty acid binding protein (H‐FABP) independently predicts all‐cause mortality in patients with light chain cardiac amyloidosis (AL‐CA). Elevated H‐FABP levels (> 9.5 ng/mL) are associated with significantly worse survival and provide incremental prognostic value beyond established staging systems, improving risk stratification as ...
Xinqing Li   +10 more
wiley   +1 more source

False‐positive bone scintigraphy denoting transthyretin amyloid in elderly hypertrophic cardiomyopathy

open access: yesESC Heart Failure, 2021
A positive nuclear scintigraphy with hydroxy bisphosphonate bone tracer (99mTc‐HPD) is believed to have high sensitivity (>99%) and specificity (91%) for the diagnosis of transthyretin amyloid cardiomyopathy. We report the case of an 85‐year‐old man with
Cristina Chimenti   +7 more
doaj   +1 more source

CMR‐derived skeletal muscle T1 time and extracellular volume as novel diagnostic markers for cardiac amyloidosis

open access: yesEuropean Journal of Clinical Investigation, Volume 56, Issue 4, April 2026.
This study compared T1 time and ECV in cardiac and thoracic skeletal muscle using CMR in 267 CA patients and 1709 non‐CA controls. Representative T1‐maps (central panel) illustrate regions of interest placed in the cardiac and thoracic skeletal muscle.
Christina Kronberger   +20 more
wiley   +1 more source

Endomyocardial biopsy in Chagas' heart disease: pathogenetic contributions

open access: yesSão Paulo Medical Journal
Endomyocardial biopsy procedure has been performed in many centers around the world, allowing a better treatment and follow up of the patients with myocardial disease.
Maria de Lourdes Higuchi
doaj   +1 more source

Case Report: Diagnosis of Dual-Biopsy Negative Severe Cardiac Amyloidosis [PDF]

open access: yes, 2016
INTRODUCTION Amyloidosis is a rare disorder that involves the deposition of misfolded protein in extracellular tissue. Disease manifestations vary depending on the affected organs.
Kasprowicz, MD, Eric, Lohr, MD, Kristin
core   +2 more sources

Two causes of COVID‐19‐related myocardial injury‐associated cardiogenic shock: Myocarditis and microvascular thrombosis

open access: yes
ESC Heart Failure, Volume 12, Issue 2, Page 1514-1522, April 2025.
Takamasa Iwai   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy